These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 23188167)

  • 1. Effects of adherence to ventilator-associated pneumonia treatment guidelines on clinical outcomes.
    Sakaguchi M; Shime N; Iguchi N; Kobayashi A; Takada K; Morrow LE
    J Infect Chemother; 2013 Aug; 19(4):599-606. PubMed ID: 23188167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locally derived versus guideline-based approach to treatment of hospital-acquired pneumonia in the trauma intensive care unit.
    Becher RD; Hoth JJ; Rebo JJ; Kendall JL; Miller PR
    Surg Infect (Larchmt); 2012 Dec; 13(6):352-9. PubMed ID: 23268613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time to Guideline-Based Empiric Antibiotic Therapy in the Treatment of Pneumonia in a Community Hospital: A Retrospective Review.
    Erwin BL; Kyle JA; Allen LN
    J Pharm Pract; 2016 Aug; 29(4):386-91. PubMed ID: 25601458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of ventilator-associated pneumonia in intensive care units: a mixed methods study assessing barriers and facilitators to guideline adherence.
    Safdar N; Musuuza JS; Xie A; Hundt AS; Hall M; Wood K; Carayon P
    BMC Infect Dis; 2016 Jul; 16():349. PubMed ID: 27448800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inappropriate antibiotic use due to decreased compliance with a ventilator-associated pneumonia computerized clinical pathway: implications for continuing education and prospective feedback.
    Wilde AM; Nailor MD; Nicolau DP; Kuti JL
    Pharmacotherapy; 2012 Aug; 32(8):755-63. PubMed ID: 23307523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and implementation of a performance improvement project in adult intensive care units: overview of the Improving Medicine Through Pathway Assessment of Critical Therapy in Hospital-Acquired Pneumonia (IMPACT-HAP) study.
    Mangino JE; Peyrani P; Ford KD; Kett DH; Zervos MJ; Welch VL; Scerpella EG; Ramirez JA;
    Crit Care; 2011; 15(1):R38. PubMed ID: 21266065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guideline-adherent initial intravenous antibiotic therapy for hospital-acquired/ventilator-associated pneumonia is clinically superior, saves lives and is cheaper than non guideline adherent therapy.
    Wilke M; Grube RF; Bodmann KF
    Eur J Med Res; 2011 Jul; 16(7):315-23. PubMed ID: 21813372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of ampicillin-sulbactam for empiric treatment of ventilator-associated pneumonia in a trauma population.
    McMillian WD; Bednarik JL; Aloi JJ; Ahern JW; Crookes BA
    J Trauma; 2010 Oct; 69(4):861-5. PubMed ID: 20938272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is a strategy based on routine endotracheal cultures the best way to prescribe antibiotics in ventilator-associated pneumonia?
    Luna CM; Sarquis S; Niederman MS; Sosa FA; Otaola M; Bailleau N; Vay CA; Famiglietti A; Irrazabal C; Capdevila AA
    Chest; 2013 Jul; 144(1):63-71. PubMed ID: 23348886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
    Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
    J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
    Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
    Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Gram Stain-Guided Initial Antibiotic Therapy on Clinical Response in Patients With Ventilator-Associated Pneumonia: The GRACE-VAP Randomized Clinical Trial.
    Yoshimura J; Yamakawa K; Ohta Y; Nakamura K; Hashimoto H; Kawada M; Takahashi H; Yamagiwa T; Kodate A; Miyamoto K; Fujimi S; Morimoto T
    JAMA Netw Open; 2022 Apr; 5(4):e226136. PubMed ID: 35394515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of antibiotic guideline compliance on duration of mechanical ventilation in critically ill patients with community-acquired pneumonia.
    Shorr AF; Bodi M; Rodriguez A; Sole-Violan J; Garnacho-Montero J; Rello J;
    Chest; 2006 Jul; 130(1):93-100. PubMed ID: 16840388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study.
    Kett DH; Cano E; Quartin AA; Mangino JE; Zervos MJ; Peyrani P; Cely CM; Ford KD; Scerpella EG; Ramirez JA;
    Lancet Infect Dis; 2011 Mar; 11(3):181-9. PubMed ID: 21256086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Gram stain results on initial treatment selection in patients with ventilator-associated pneumonia: a retrospective analysis of two treatment algorithms.
    Yoshimura J; Kinoshita T; Yamakawa K; Matsushima A; Nakamoto N; Hamasaki T; Fujimi S
    Crit Care; 2017 Jun; 21(1):156. PubMed ID: 28625166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
    Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
    Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Length of stay and hospital costs associated with a pharmacodynamic-based clinical pathway for empiric antibiotic choice for ventilator-associated pneumonia.
    Nicasio AM; Eagye KJ; Kuti EL; Nicolau DP; Kuti JL
    Pharmacotherapy; 2010 May; 30(5):453-62. PubMed ID: 20411997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-adherence to guidelines: an avoidable cause of failure of empirical antimicrobial therapy in the presence of difficult-to-treat bacteria.
    Garcin F; Leone M; Antonini F; Charvet A; Albanèse J; Martin C
    Intensive Care Med; 2010 Jan; 36(1):75-82. PubMed ID: 19777208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tackling empirical antibiotic therapy for ventilator-associated pneumonia in your ICU: guidance for implementing the guidelines.
    Kuti JL; Shore E; Palter M; Nicolau DP
    Semin Respir Crit Care Med; 2009 Feb; 30(1):102-15. PubMed ID: 19199192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.